Evan Seigerman | BiotechTV

top of page

BMO's Evan Seigerman joins Analyst Thursdays from London

Evan Seigerman discusses news from #AHA23, what's going on with Structure, Verve's polarizing result, Neurocrine, Vertex, Pfizer and more.

BMO Capital Markets’ Evan Seigerman joins BiotechTV for Analyst Thursdays

Evan Seigerman gives his take on biotech and the CMS list, Lilly, Amgen, Skyscraper-01, Structure Therapeutics, Disc Medicine and Replimune.

Also look for unique social pages for BiotechTV U.